# Northrop Grumman Corp: financial statements, quarterly

NOC · NYSE · CIK 1133421 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/noc.md) · [Financials](/companies/noc/financials.md) · [Filings](/companies/noc/filings.md) · [Insiders](/companies/noc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/noc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.6 d](/filings/0001133421-26-000003.md) | [10.1](/filings/0001133421-25-000023.md) | [10.2](/filings/0001133421-25-000049.md) | [10.0](/filings/0001133421-25-000053.md) | [10.7 d](/filings/0001133421-26-000003.md) | [9.5](/filings/0001133421-26-000016.md) | [10.4](/filings/0001133421-26-000034.md) | [10.4](/filings/0001133421-26-000038.md) | [11.7 d](/filings/0001133421-26-000003.md) | [9.9](/filings/0001133421-26-000016.md) | [10.9](/filings/0001133421-26-000034.md) | [11.1](/filings/0001133421-26-000038.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [(0.4) d](/filings/0001133421-26-000003.md) | [1.1](/filings/0001133421-25-000023.md) | [1.1](/filings/0001133421-25-000049.md) | [1.1](/filings/0001133421-25-000053.md) | [1.1 d](/filings/0001133421-26-000003.md) | [0.6](/filings/0001133421-26-000016.md) | [1.4](/filings/0001133421-26-000034.md) | [1.2](/filings/0001133421-26-000038.md) | [1.3 d](/filings/0001133421-26-000003.md) | [1.0](/filings/0001133421-26-000016.md) | [1.1](/filings/0001133421-26-000034.md) | [1.3](/filings/0001133421-26-000038.md) |
| Income tax | $bn | [(0.2) d](/filings/0001133421-26-000003.md) | [0.2](/filings/0001133421-25-000023.md) | [0.2](/filings/0001133421-25-000049.md) | [0.2](/filings/0001133421-25-000053.md) | [0.3 d](/filings/0001133421-26-000003.md) | [0.1](/filings/0001133421-26-000016.md) | [0.3](/filings/0001133421-26-000034.md) | [0.2](/filings/0001133421-26-000038.md) | [0.3 d](/filings/0001133421-26-000003.md) | [0.2](/filings/0001133421-26-000016.md) | [0.1](/filings/0001133421-26-000034.md) | [0.2](/filings/0001133421-26-000038.md) |
| Net income | $bn | [(0.5) d](/filings/0001133421-26-000003.md) | [0.9](/filings/0001133421-25-000023.md) | [0.9](/filings/0001133421-25-000049.md) | [1.0](/filings/0001133421-25-000053.md) | [1.3 d](/filings/0001133421-26-000003.md) | [0.5](/filings/0001133421-26-000016.md) | [1.2](/filings/0001133421-26-000034.md) | [1.1](/filings/0001133421-26-000038.md) | [1.4 d](/filings/0001133421-26-000003.md) | [0.9](/filings/0001133421-26-000016.md) | [1.1](/filings/0001133421-26-000034.md) | [1.1](/filings/0001133421-26-000038.md) |
| Diluted EPS | $ per share | not reported | [6.32](/filings/0001133421-25-000023.md) | [6.36](/filings/0001133421-25-000049.md) | [7.00](/filings/0001133421-25-000053.md) | not reported | [3.32](/filings/0001133421-26-000016.md) | [8.15](/filings/0001133421-26-000034.md) | [7.67](/filings/0001133421-26-000038.md) | not reported | [6.14](/filings/0001133421-26-000016.md) | [7.68](/filings/0001133421-26-000034.md) | [7.89](/filings/0001133421-26-000038.md) |
| Basic EPS | $ per share | not reported | [6.34](/filings/0001133421-25-000023.md) | [6.37](/filings/0001133421-25-000049.md) | [7.02](/filings/0001133421-25-000053.md) | not reported | [3.33](/filings/0001133421-26-000016.md) | [8.17](/filings/0001133421-26-000034.md) | [7.69](/filings/0001133421-26-000038.md) | not reported | [6.16](/filings/0001133421-26-000016.md) | [7.70](/filings/0001133421-26-000034.md) | [7.91](/filings/0001133421-26-000038.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.1](/filings/0001133421-24-000064.md) | [3.1](/filings/0001133421-25-000023.md) | [3.3](/filings/0001133421-25-000049.md) | [3.3](/filings/0001133421-25-000053.md) | [4.4](/filings/0001133421-26-000003.md) | [1.7](/filings/0001133421-25-000023.md) | [1.9](/filings/0001133421-25-000049.md) | [2.0](/filings/0001133421-25-000053.md) | [4.4](/filings/0001133421-26-000038.md) | [2.1](/filings/0001133421-26-000016.md) | [2.3](/filings/0001133421-26-000034.md) | [3.7](/filings/0001133421-26-000038.md) |
| Current assets | $bn | [13.7](/filings/0001133421-25-000006.md) | [14.8](/filings/0001133421-24-000026.md) | [14.3](/filings/0001133421-24-000052.md) | [14.3](/filings/0001133421-24-000064.md) | [14.3](/filings/0001133421-26-000003.md) | [13.3](/filings/0001133421-25-000023.md) | [14.0](/filings/0001133421-25-000049.md) | [14.1](/filings/0001133421-25-000053.md) | [15.3](/filings/0001133421-26-000038.md) | [14.8](/filings/0001133421-26-000016.md) | [15.6](/filings/0001133421-26-000034.md) | [17.0](/filings/0001133421-26-000038.md) |
| Total assets | $bn | [46.5](/filings/0001133421-25-000006.md) | [47.8](/filings/0001133421-24-000026.md) | [47.7](/filings/0001133421-24-000052.md) | [48.3](/filings/0001133421-24-000064.md) | [49.4](/filings/0001133421-26-000003.md) | [48.5](/filings/0001133421-25-000023.md) | [49.5](/filings/0001133421-25-000049.md) | [49.3](/filings/0001133421-25-000053.md) | [51.4](/filings/0001133421-26-000038.md) | [50.0](/filings/0001133421-26-000016.md) | [50.8](/filings/0001133421-26-000034.md) | [52.5](/filings/0001133421-26-000038.md) |
| Current liabilities | $bn | [11.9](/filings/0001133421-25-000006.md) | [13.1](/filings/0001133421-24-000026.md) | [12.9](/filings/0001133421-24-000052.md) | [13.1](/filings/0001133421-24-000064.md) | [14.1](/filings/0001133421-26-000003.md) | [14.0](/filings/0001133421-25-000023.md) | [13.5](/filings/0001133421-25-000049.md) | [12.7](/filings/0001133421-25-000053.md) | [13.9](/filings/0001133421-26-000038.md) | [12.8](/filings/0001133421-26-000016.md) | [13.3](/filings/0001133421-26-000034.md) | [13.8](/filings/0001133421-26-000038.md) |
| Total liabilities | $bn | [31.7](/filings/0001133421-25-000006.md) | [33.6](/filings/0001133421-24-000026.md) | [33.4](/filings/0001133421-24-000052.md) | [33.5](/filings/0001133421-24-000064.md) | [34.1](/filings/0001133421-26-000003.md) | [33.5](/filings/0001133421-25-000023.md) | [34.0](/filings/0001133421-25-000049.md) | [33.3](/filings/0001133421-25-000053.md) | [34.7](/filings/0001133421-26-000038.md) | [32.9](/filings/0001133421-26-000016.md) | [32.9](/filings/0001133421-26-000034.md) | [33.8](/filings/0001133421-26-000038.md) |
| Long-term debt | $bn | [13.8](/filings/0001133421-25-000006.md) | [14.7](/filings/0001133421-24-000026.md) | [14.7](/filings/0001133421-24-000052.md) | [14.7](/filings/0001133421-24-000064.md) | [14.7](/filings/0001133421-26-000003.md) | [14.2](/filings/0001133421-25-000023.md) | [15.2](/filings/0001133421-25-000049.md) | [15.2](/filings/0001133421-25-000053.md) | [15.2](/filings/0001133421-26-000038.md) | [14.4](/filings/0001133421-26-000016.md) | [14.4](/filings/0001133421-26-000034.md) | [14.4](/filings/0001133421-26-000038.md) |
| Current portion of debt | $bn | [0.1](/filings/0001133421-25-000006.md) | [1.6](/filings/0001133421-24-000026.md) | [1.6](/filings/0001133421-24-000052.md) | [1.6](/filings/0001133421-24-000064.md) | [1.6](/filings/0001133421-26-000003.md) | [0.6](/filings/0001133421-25-000023.md) | [0.6](/filings/0001133421-25-000049.md) | [0.5](/filings/0001133421-25-000053.md) | [0.5](/filings/0001133421-26-000038.md) | [0.8](/filings/0001133421-26-000016.md) | [0.8](/filings/0001133421-26-000034.md) | [0.8](/filings/0001133421-26-000038.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [14.8](/filings/0001133421-26-000003.md) | [14.2](/filings/0001133421-25-000023.md) | [14.3](/filings/0001133421-25-000049.md) | [14.7](/filings/0001133421-25-000053.md) | [15.3](/filings/0001133421-26-000003.md) | [15.0](/filings/0001133421-26-000016.md) | [15.5](/filings/0001133421-26-000034.md) | [16.0](/filings/0001133421-26-000038.md) | [16.7](/filings/0001133421-26-000038.md) | [17.1](/filings/0001133421-26-000016.md) | [17.9](/filings/0001133421-26-000034.md) | [18.7](/filings/0001133421-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,430 d](/filings/0001133421-26-000003.md) | [(706)](/filings/0001133421-25-000023.md) | [1,425 d](/filings/0001133421-25-000049.md) | [1,091 d](/filings/0001133421-25-000053.md) | [2,578 d](/filings/0001133421-26-000003.md) | [(1,565)](/filings/0001133421-26-000016.md) | [868 d](/filings/0001133421-26-000034.md) | [1,557 d](/filings/0001133421-26-000038.md) | [3,897 d](/filings/0001133421-26-000003.md) | [(1,656)](/filings/0001133421-26-000016.md) | [1,280 d](/filings/0001133421-26-000034.md) | [1,745 d](/filings/0001133421-26-000038.md) |
| Capital expenditure | $m | [803 d](/filings/0001133421-26-000003.md) | [270](/filings/0001133421-25-000023.md) | [320](/filings/0001133421-25-000049.md) | [361](/filings/0001133421-25-000053.md) | [816 d](/filings/0001133421-26-000003.md) | [256](/filings/0001133421-26-000016.md) | [231](/filings/0001133421-25-000049.md) | [301](/filings/0001133421-25-000053.md) | [662 d](/filings/0001133421-26-000003.md) | [167](/filings/0001133421-26-000016.md) | [302 d](/filings/0001133421-26-000034.md) | [306 d](/filings/0001133421-26-000038.md) |
| Dividends paid | $m | [282 d](/filings/0001133421-26-000003.md) | [283](/filings/0001133421-25-000023.md) | [303 d](/filings/0001133421-25-000049.md) | [301 d](/filings/0001133421-25-000053.md) | [299 d](/filings/0001133421-26-000003.md) | [302](/filings/0001133421-26-000016.md) | [332 d](/filings/0001133421-26-000034.md) | [330 d](/filings/0001133421-26-000038.md) | [329 d](/filings/0001133421-26-000003.md) | [333](/filings/0001133421-26-000016.md) | [351 d](/filings/0001133421-26-000034.md) | [351 d](/filings/0001133421-26-000038.md) |
| Share repurchases | $m | [346 d](/filings/0001133421-26-000003.md) | [1,190](/filings/0001133421-25-000023.md) | [562 d](/filings/0001133421-25-000049.md) | [321 d](/filings/0001133421-25-000053.md) | [441 d](/filings/0001133421-26-000003.md) | [480](/filings/0001133421-26-000016.md) | [411 d](/filings/0001133421-26-000034.md) | [277 d](/filings/0001133421-26-000038.md) | [456 d](/filings/0001133421-26-000003.md) | [68.0](/filings/0001133421-26-000016.md) | [0.0 d](/filings/0001133421-26-000034.md) | [0.0 d](/filings/0001133421-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [153](/filings/0001133421-24-000026.md) | [152](/filings/0001133421-24-000052.md) | [152](/filings/0001133421-24-000064.md) | [149](/filings/0001133421-25-000023.md) | [148](/filings/0001133421-25-000049.md) | [147](/filings/0001133421-25-000053.md) | [145](/filings/0001133421-26-000016.md) | [144](/filings/0001133421-26-000034.md) | [144](/filings/0001133421-26-000038.md) | [143](/filings/0001133421-26-000016.md) | [142](/filings/0001133421-26-000034.md) | [142](/filings/0001133421-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 142,064,489 at 2026-10-15, from the cover of the [10-Q filed 2026-10-20](/filings/0001133421-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.